| Product NDC: | 68209-843 |
| Proprietary Name: | Octagam Immune Globulin (Human) |
| Non Proprietary Name: | Immune Globulin |
| Active Ingredient(s): | 50 mg/mL & nbsp; Immune Globulin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68209-843 |
| Labeler Name: | Octapharma AB |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125062 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20060414 |
| Package NDC: | 68209-843-01 |
| Package Description: | 20 mL in 1 BOTTLE, GLASS (68209-843-01) |
| NDC Code | 68209-843-01 |
| Proprietary Name | Octagam Immune Globulin (Human) |
| Package Description | 20 mL in 1 BOTTLE, GLASS (68209-843-01) |
| Product NDC | 68209-843 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Immune Globulin |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060414 |
| Marketing Category Name | BLA |
| Labeler Name | Octapharma AB |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |